On April 24, 2026, the “Decree amending and adding various provisions to the Health Supplies Regulations” (the “Decree”) was published in the Federal Official Gazette, introducing significant changes regarding patent compensation for delays in the issuance of marketing authorizations, regulatory data protection, and the technical meeting with the New Molecules Committee.